Edwards Lifesciences | EW - Interest Expense On Debt



Edwards Lifesciences reported 15.5M in Interest Expense on Debt for its fiscal quarter ending in June of 2024.


Interest Expense On Debt Change Date
Abbott USD 50M 1000K Jun/2025
AtriCure USD 1.35M 79K Jun/2025
Baxter International USD 81M 19M Mar/2025
Becton, Dickinson and Co. USD 152M 1000K Jun/2025
Boston Scientific USD 90M 8M Jun/2025
Cooper Companies USD 25.4M 1.2M Jul/2025
Dexcom USD 4.7M 0 Jun/2025
Edwards Lifesciences 15.5M 1000K Jun/2024
Globus Medical 4K 9K Jun/2025
Hologic USD 28.9M 200K Jun/2025
ICU Medical USD 23.06M 1.03M Jun/2025
Insulet USD 9.5M 8.3M Jun/2025
Integra LifeSciences USD 21.04M 2.23M Jun/2025
Intuitive Surgical 74.9M 18.8M Dec/2024
J&J USD 128M 9M Mar/2025
Masimo USD 8.2M 600K Jun/2025
Medtronic USD 176M 2M Jul/2025
Merit Medical Systems USD 6.78M 207K Jun/2025
Stryker 42M 11M Sep/2024
Tandem Diabetes Care USD 1.9M 43K Jun/2025
Teleflex USD 21.71M 3.16M Jun/2025
Zimmer Biomet Holdings USD 79.3M 17.4M Jun/2025